Product Details

Veram-C Capsules meet Indian Pharmacopoeia (IP) standards for the treatment of serious bacterial infections. Specifically, each capsule delivers Chloramphenicol IP at 500mg. As a result, it offers potent broad-spectrum antibacterial coverage reserved for infections where other antibiotics are unsuitable or ineffective.

The capsules contain:

• Chloramphenicol IP (500mg) – A broad-spectrum antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. Consequently, it exerts bacteriostatic, and at higher concentrations bactericidal, activity against a wide range of gram-positive and gram-negative organisms, including many resistant strains.

Physicians prescribe Veram-C for the treatment of serious bacterial infections such as typhoid fever, bacterial meningitis, and certain infections where first-line antibiotics have failed or are contraindicated. In addition, its broad-spectrum activity makes it valuable in select severe or resistant infections under close medical supervision. Because of this profile, Veram-C suits hospital and specialist settings managing serious bacterial infections that require careful monitoring during treatment.

Key Features:

• Overall, this IP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the oral capsule format supports structured dosing under medical supervision
• Furthermore, each capsule delivers precise, validated dosage accuracy at 500mg
• Notably, rigorous quality testing backs every stage of manufacturing
• Beyond that, blister packaging protects capsule integrity against light
• Ultimately, a reliable supply chain suits bulk distribution to hospitals and specialist clinics